Eltrombopag Olamine

CAS 496775-62-3
Back to the Catalog Contact us about this API

General Information

Eltrombopag olamine a type of thrombopoietin receptor agonist and is used to treat thrombocytopenia (a lower-than-normal number of platelets in the blood) in patients with chronic immune thrombocytopenic purpura (a condition in which platelets are destroyed by the immune system).

About the API

Technology Synthetic
Molecular Weight 564.6 g/mol
Therapeutic category Hematology
Available formulations Oral Solid
Regulations EU DMF Flag EU DMF

Updates about Eltrombopag Olamine

  • Dec 29, 2021 EU DMF

Related API products

Deferasirox 201530-41-8 Eptifibatide 188627-80-7 Deferoxamine mesylate 138-14-7 Bivalirudin 128270-60-0

Make sure to check out our blog. Expert’s posts and community.
Browse Our Blog
Make sure to check out our blog. Expert’s posts and community.

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.

For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.

This site uses cookies (unless you have disabled them) to give you a better and personalized browsing experience and targeted ads.
By continuing your visit on this website, you agree to the use of Cookies on your device. Find out more in our Privacy Policy